The labelling of Nanocoll® with [111In] for dual-isotope scanning

Applied Radiation and Isotopes

Volumn 59, Issue 5-6, 2003, Pages 337-342

  Mitterhauser, Markus ^a,b   Wadsak, Wolfgang ^b,d   Mien, Leonhard Key ^b   Eidherr, Harald ^b   Roka, Sebastian ^b   Zettinig, Georg ^b,d   Angelberger, Peter ^c   Viernstein, Helmut ^b   Kletter, Kurt ^b   Dudczak, Robert ^b,d  

^a Anstaltsapotheke Allgemeinen K   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ARC SEIBERSDORF RESEARCH GMBH   (Austria)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Breast cancer; Dual nuclide; Particle size; Sentinel lymph node; 111In Nanocoll

Indexed keywords

BIOPSY; BLOOD VESSELS; PARTICLE SIZE ANALYSIS; TUMORS;

LYMPH NODES;

RADIOISOTOPES;

ACETIC ACID; BUFFER; CHLORINE DERIVATIVE; INDIUM 111; NANOCOLL IN 111; NANOCOLL TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; INDIUM; MACROSALB TC 99M; TECHNETIUM TC 99M NANOCOLLOID;

ARTICLE; FILTER; FILTRATION; ISOTOPE LABELING; PARTICLE SIZE; PRIORITY JOURNAL; SCINTISCANNING; CHEMISTRY; METHODOLOGY; QUALITY CONTROL; SYNTHESIS;

INDIUM RADIOISOTOPES; ISOTOPE LABELING; PARTICLE SIZE; QUALITY CONTROL; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0242485367     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2003.09.002     Document Type: Article

References (20)

1. Bedrosian I., Scheff A.M., Mick R., Callans L.S., Bucky L.P., Spitz F.R., Helsabeck C., Elder D.E., Alavi A., Fraker D.F., Czerniecki B.J. 99m-Tc human serum albumin. an effective radiotracer for identifying sentinel lymph nodes in melanoma J. Nucl. Med. 40:1999;1143-1148.
2. Berqvist L., Strand S.E. Autocorrelation spectroscopy for particle sizing and stability tests of radiolabelled colloids. Eur. J. Nucl. Med. 15:1989;641-645.
3. Gallowitsch, H.J., Konstantiniuk, P., Jörg, L., Urbania, A., Kugler, F., Peschina, W., Hatzl-Griesenhofer, M., Zettinig, G., 2002. Identification of sentinel lymph nodes in breast cancer by lymphoscintigraphy and gamma probe guidance: dependence on route of injection and tumor location. Europ. Surg. 34, in press.
4. Goldie H., Hahn P.F. Distribution and effect of colloidal radioactive gold in peritoneal fluid containing free sarcoma 37 cells. Proc. Soc. Exp. Biol. Med. 74:1950;638-642.
5. Gommans G.M.M., Van Dongen A., Van der Schors T.G., Gommans E., Visser J.F.M., Clarijs W.W.J., De Waard J.W.D., Van de Bos J., Boer R.O. Further optimisation of 99m-Tc-Nanocoll sentinel node localisation in carcinoma of the breast by improved labelling. Eur. J. Nucl. Med. 28:2001;1450-1455.
6. Hnatowich D.J., Layne W.W., Childs R.L. The preparation and labelling of DTPA-coupled Albumin. Int. J. Appl. Radiat. Isot. 33:1982;327-332.
7. Keshtgar M.R.S., Ell P.J. Sentinel lymph node detection and imaging. Eur. J. Nucl. Med. 26:1999;57-67.
8. Krag D., Moffot F. Nuclear medicine and the surgeon. Lancet. 354:1999;1019-1022.
9. McMasters K.M., Tuttle T.M., Carlson D.J., Brown C.M., Noyes R.D., Glaser R.L., Vennekotter D.J., Turk P.S., Tate P.S., Sardi A., Cerrito P.B., Edwards M.J. Sentinel lymph node biopsy for breast cancer. a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used J. Clin. Oncol. 18:2000;2560-2566.
10. Mullan M.H., Deacock S.J., Quiney N.F., Kissin M.W. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer. Eur. J. Surg. Oncol. 27:2001;218-219.
11. Nycomed Amersham Sorin S.r.l. Package insert Nanocoll. 1999;SPC November.
12. Oliveira Filho R.S., Santos I.D., Ferreira L.M., de Almeida F.A., Simões e Silvia Enokihara M.M., Barbieri A., Tovo Filho R. Is intra-operative gamma probe detection really necessary for inguinal sentinel lymph node biopsy? Sao Paulo Med. J. 118:2000;165-168.
13. Petit W.A., Deland F.H., Pepper G.H., Blanton L. Albumin characterization of Tin-Technetium colloid in technetium-labelled preparations. J. Nucl. Med. 19:1978;387-392.
14. Pijpers R., Meijer S., Hoekstra O.S., Collet G.J., Comans E.F.I., Boom R.P.A., van Diest P.J., Teule G.J.J. Impact of lymphoscintigraphy on sentinel node identification with 99m-technetium colloidal albumin in breast cancer. J. Nucl. Med. 38:1997;366-368.
15. Roumen R.M.H., Geusken L.M., Valkenburg J.G.H. In search of the true sentinel node by different injection techniques in breast cancer patients. Eur. J. Surg. Oncol. 25:1999;347-351.
16. Strand S.E., Persson B.R. Quantitative lymphoscintigraphy. basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits J. Nucl. Med. 20:1979;1038-1046.
17. Tsugawa K., Noguchi M., Miwa K., Bando E., Yokoyama K., Nakajima K., Michigishi T., Tonami N., Minato H., Nonomura H. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients. using patent blue dye and technetium-99m-labeled human serum albumin Breast Cancer. 7:2000;87-94.
18. Van der Ent F.C.W., Kengen R.A.M., Van der Pol H.A.G., Hoofwijk A.G.M. Sentinel node biopsy in 70 unselected patients with breast cancer. increased feasibility by using 10mCi radiocolloid in combination with a blue dye tracer Eur. J. of Surg. Oncol. 25:1999;24-29.
19. Watanabe N., Shirakami Y., Tomiyoshi K., Oriuchi N., Hirano T., Yukihiro M., Inoue T., Endo K. Indirect labeling of macroaggregated albumin with 111-In via diethylenetriaminepentaacetic acid. Nucl. Med. Biol. 23:1996;595-598.
20. Wilhelm A.J., Mijnhout G.S., Franssen E.J.F. Radiopharmaceuticals in sentinel lymph node detection. an overview Eur. J. Nucl. Med. S1(26):1999;36-42.